| [hepatitis c virus infection in female sexual workers from northern lima]. | hepatitis c is the second major endemic viral infection in the world after hiv. in the usa it is the first liver transplant indication. currently, the main risk factors to develop this disease are history of blood transfusions and iv drug usage. sexual transmission remains controversial and accounts probably for less than 5% of case transmissions. | 2003 | 14716421 |
| [hepatitis c virus infection in blood bank donors at the hospital nacional cayetano heredia (1998 - 2002)]. | hepatitis c virus infection (hcv) is the main cause for chronic hepatic disease around the world. nowadays, there are highly sensitive and specialized tests such as third generation elisa, used to detect anti-hcv antibodies and to prevent its transmission. since 1998, this test has been applied to blood donors in our hospital. the objectives of this study were to determine the predominance and some epidemiological characteristics of the hcv infection in blood donors at the cayetano heredia natio ... | 2003 | 12768211 |
| hepatitis c in peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution. | a large seroepidemiologic and genotyping study of hepatitis c virus (hcv) was conducted in lima, peru, during the periods of 1986 to 1993 (cohort a) and 1994 (cohort b). anti-hcv seroprevalence rates were 15.6% (216 of 1,389) and 11.7% (168 of 1,438), respectively. low rates were seen among volunteer blood donors (1.1% and 0.8%). anti-hcv rates were much higher among patients undergoing hemodialysis (43.7% and 59.3%), hemophiliacs (60.0% and 83.3%), in those more than 39 years old (18.2% and 26. ... | 2000 | 11421371 |
| chronic liver disease in peru: role of viral hepatitis. | the prevalence of antibodies to hepatitis c virus (anti-hcv) was determined in 105 patients with biopsy-proven chronic liver disease and 128 comparison patients without any evidence of liver pathology living in lima, peru. using a second-generation eia screening and supplemental immunoblot assay, anti-hcv was detected in four of 13 patients with chronic hepatitis, in 11% of 85 patients with cirrhosis, and in none of seven patients with hepatocellular carcinoma. only two (1.6%) comparison patient ... | 1994 | 8158107 |